Abiopharma

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0001918704-26-010220 <b>Size:</b> 677 KB

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0001918704-26-010219 <b>Size:</b> 865 KB

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0000950103-26-005921 <b>Size:</b> 334 KB

(75% Positive) FERMI INC. (FRMI) Announces Business Combination

NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference

New Form 13F-HR - First Bancorp, Inc /ME/ <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0000765207-26-000072 <b>Size:</b> 92 KB

New Form 424B2 - ROYAL BANK OF CANADA <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0000950103-26-005920 <b>Size:</b> 271 KB

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: CHANGE IN INTEREST OF DIRECTOR - BENEDICT LEH SONG BOON

(99% Neutral) OWENS CORNING (OC) Files Form 8-K

(99% Positive) WW INTERNATIONAL, INC. (WW) Reports Q2 2026 Financial Results

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: CHANGE IN INTEREST OF DIRECTOR - QUEK SEE TIAT

New Form 424B2 - ROYAL BANK OF CANADA <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0000950103-26-005919 <b>Size:</b> 254 KB

(90% Positive) NEUROGENE INC. (NGNE) Provides Update on companies for rare neurological diseases

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0001918704-26-010218 <b>Size:</b> 573 KB

Nexera: KeepZone AI Enters into White Label Agreement to Develop its AI-Based Voice Communication Decision Support System